The levels of NLR, MIP-1β, TNF-α, IL-17A in the GN-BSI group were significantly higher than those in the GP-BSI group (P < .001, P < .001, P < .001, and P = .010). The gene discussed is CCL4; the disease is ganglioneuroma.